Literature DB >> 11745333

PEBP2 and c-myb sites crucial for lambda5 core enhancer activity in pre-B cells.

A Mårtensson1, X Q Xie, C Persson, M Holm, T Grundström, I L Mårtensson.   

Abstract

The lambda5 gene is expressed exclusively in precursor (pre-) B cells where its gene product, as part of the pre-B cell receptor, is crucial for the proliferation of these cells. Several DNA regions regulate the activity and expression pattern of the lambda5 gene. Amongst these is an enhancer, B(lambda5), located 5' of the gene. Here we analyze the lambda5 enhancer core, b(lambda5), which in earlier experiments was demonstrated to retain 50% of the enhancer activity, and show that this activity is restricted to pre-B cells. We identify a DNA element within b(lambda5), PEBP2(lambda5), which is essential for enhancer activity: mutation within this site dramatically reduces core enhancer activity in pre-B cells. The PEBP2(lambda5) site binds bacterially produced polyoma enhancer binding proteins (PEBP) (Runx/AML/CBFA). Furthermore, PEBP2 proteins present in nuclear extracts from murine pre-B cells bind to the PEBP2(lambda5) element. PEBP2 proteins in mature B cells also bind to the PEBP2(lambda5 )element, implying that if PEBP2 proteins are responsible for the stage-specific expression, they have to be non-activating or inhibiting in mature B cells. We also demonstrate that a described partner of PEBP2, c-myb, binds to a sequence termed myb(lambda5) located just upstream of the PEBP2(lambda5) site in the core enhancer. The myb(lambda5) element is also crucial for enhancer activity, since mutating the myb site reduces core enhancer activity to the same extent as mutating the PEBP2 site. Earlier reports have shown that c-myb is expressed at high levels in pre-B cell lines whereas its expression is down-regulated in more mature B cell lines. Thus, c-myb may be involved in determining the stage-specific expression of the lambda5 gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745333     DOI: 10.1002/1521-4141(200111)31:11<3165::aid-immu3165>3.0.co;2-n

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  The RUNX complex: reaching beyond haematopoiesis into immunity.

Authors:  Dominic Chih-Cheng Voon; Yit Teng Hor; Yoshiaki Ito
Journal:  Immunology       Date:  2015-10-25       Impact factor: 7.397

2.  c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint.

Authors:  Shawn P Fahl; Andrea R Daamen; Rowena B Crittenden; Timothy P Bender
Journal:  J Immunol       Date:  2018-04-13       Impact factor: 5.422

3.  Cbfbeta-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development.

Authors:  Ya-Huei Kuo; Rachel M Gerstein; Lucio H Castilla
Journal:  Blood       Date:  2007-10-16       Impact factor: 22.113

4.  Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.

Authors:  Shinobu Tsuzuki; Masao Seto; Mel Greaves; Tariq Enver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

5.  Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre-B Cell Proliferation by Affecting Runx/CBFβ-targeted VpreB and λ5 Genes.

Authors:  Seung-Young Choi; Sung-Kyun Park; Han-Woong Yoo; Joo-Hyun Pi; Chang-Joong Kang
Journal:  J Biol Chem       Date:  2016-05-19       Impact factor: 5.157

6.  A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.

Authors:  Ruli Gao; Chunxia Cao; Min Zhang; Maria-Cecilia Lopez; Yuanqing Yan; Zirong Chen; Yoshitsugu Mitani; Li Zhang; Maria Zajac-Kaye; Bin Liu; Lizi Wu; Rolf Renne; Henry V Baker; Adel El-Naggar; Frederic J Kaye
Journal:  Oncotarget       Date:  2014-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.